Autor: "Barohn, Richard J" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Using a Bayesian model of the joint distribution of pain and time on medication to decide on pain medication for neuropathy.
Autorzy:: Gao G; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA.
Wick JA; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA.
Brown AR; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA.
Barohn RJ; Department of Neurology, University of Missouri, Columbia, USA.
Gajewski BJ; Department of Biostatistics & Data Science, University of Kansas Medical Center, Kansas City, USA.; Pokaż więcej
Źródło:: Communications in statistics. Case studies, data analysis and applications [Commun Stat Case Stud Data Anal Appl] 2023; Vol. 9 (3), pp. 252-269. Date of Electronic Publication: 2023 May 19.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Oxaloacetate treatment preserves motor function in SOD1 mice and normalizes select neuroinflammation-related parameters in the spinal cord.
Autorzy:: Tungtur SK; Department of Anatomy and Cell Biology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.; Cardiovascular Division, University of Minnesota School of Medicine, Minneapolis, MN, 55455, USA.
Wilkins HM; Department of Neurology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.
Rogers RS; Department of Anatomy and Cell Biology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.; Department of Curriculum and Integrative Learning, Kansas City University, Joplin, MO, 64804, USA.
Badawi Y; Department of Anatomy and Cell Biology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.; Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Sage JM; Department of Basic Sciences, Kansas City University, Kansas City, MO, 64106, USA.
Agbas A; Department of Basic Sciences, Kansas City University, Kansas City, MO, 64106, USA.
Jawdat O; Department of Neurology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.
Barohn RJ; Department of Neurology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.; Department of Neurology, University Missouri-Columbia, Columbia, MO, 65212, USA.
Swerdlow RH; Department of Neurology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA.
Nishimune H; Department of Anatomy and Cell Biology, School of Medicine, University of Kansas, Kansas City, KS, 66160, USA. .; Tokyo Metropolitan Institute of Gerontology, Neurobiology of Aging, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 May 26; Vol. 11 (1), pp. 11051. Date of Electronic Publication: 2021 May 26.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Amyotrophic Lateral Sclerosis/*metabolism
Motor Activity/*drug effects
Oxaloacetic Acid/*pharmacology
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/*metabolism
Spinal Cord/*drug effects
Tumor Necrosis Factor-alpha/*metabolism
Animals ; Disease Models, Animal ; Inflammation/drug therapy ; Inflammation/metabolism ; Longevity/drug effects ; Mice ; Motor Neurons/drug effects ; Motor Neurons/metabolism ; Oxaloacetic Acid/therapeutic use ; Spinal Cord/metabolism ; Superoxide Dismutase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The clinical spectrum of primary lateral sclerosis.
Autorzy:: Barohn RJ; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Fink JK; Department of Neurology, Ann Arbor Veterans Affairs Medical Center, University of Michigan, Ann Arbor, MI, USA.
Heiman-Patterson T; Department of Neurology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Huey ED; College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Murphy J; Department of Neurology, University of California at San Francisco, San Francisco, CA, USA.
Statland JM; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Turner MR; Nuffield Department of Neurosciences, University of Oxford, Oxford, UK.
Elman L; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Pokaż więcej
Źródło:: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2020 Nov; Vol. 21 (sup1), pp. 3-10.
Typ publikacji:: Journal Article
MeSH Terms:: Amyotrophic Lateral Sclerosis*/diagnosis
Motor Neuron Disease*/diagnosis
Humans ; Leg ; Phenotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis.
Autorzy:: Mitsumoto H; Department of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Garofalo DC; Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.
Santella RM; Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University Medical Center, New York, NY, USA.
Sorenson EJ; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Oskarsson B; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Fernandes JAM Jr; Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Andrews H; Data Coordinating Center (DCC), Mailman School of Public Health Biostatistics Department, Columbia University Irving Medical Center, New York State Psychiatric Institute & Department of Psychiatry, Columbia University.
Hupf J; Department of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Gilmore M; Department of Neurology, Eleanor and Lou Gehrig ALS Center, Columbia University Irving Medical Center, New York, NY, USA.
Heitzman D; Texas Neurology, PA, Dallas, TX, USA.
Bedlack RS; Department of Neurology, Duke University, Durham, NC, USA.
Katz JS; Forbes Norris ALS Center, California Pacific Medical Center, San Francisco, CA, USA.
Barohn RJ; Department of Neurology, University of Kansas, San Francisco, CA, USA.
Kasarskis EJ; Department of Neurology, University of Kentucky, San Francisco, CA, USA.
Lomen-Hoerth C; Department of Neurology, University of California, San Francisco, CA, USA.
Mozaffar T; Department of Neurology, University of California, Irvine, CA, USA.
Nations SP; Department of Neurology and Neurotherapeutics, University of Texas Southwestern, Dallas, TX, USA, and.
Swenson AJ; Department of Neurology, University of Iowa, Iowa City, IA, USA.
Factor-Litvak P; Department of Epidemiology, Mailman School of Public Health, Columbia University Irving Medical Center, New York, NY, USA.; Pokaż więcej
Źródło:: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2020 May; Vol. 21 (3-4), pp. 263-272. Date of Electronic Publication: 2020 Apr 10.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyotrophic Lateral Sclerosis/*blood
Amyotrophic Lateral Sclerosis/*diagnosis
Creatinine/*blood
Oxidative Stress/*physiology
Adult ; Aged ; Aged, 80 and over ; Amyotrophic Lateral Sclerosis/mortality ; Biomarkers/blood ; Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prospective Studies ; Survival Rate/trends ; Uric Acid/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Lingual-Alveolar Contact Pressure During Speech in Amyotrophic Lateral Sclerosis: Preliminary Findings.
Autorzy:: Searl J; Hearing and Speech Department, University of Kansas Medical Center, Kansas City.
Knollhoff S; Hearing and Speech Department, University of Kansas Medical Center, Kansas City.
Barohn RJ; Department of Neurology, University of Kansas Medical Center, Kansas City.; Pokaż więcej
Źródło:: Journal of speech, language, and hearing research : JSLHR [J Speech Lang Hear Res] 2017 Apr 14; Vol. 60 (4), pp. 810-825.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Alveolar Process*/physiopathology
Amyotrophic Lateral Sclerosis/*physiopathology
Motor Activity/*physiology
Speech/*physiology
Tongue/*physiopathology
Adult ; Aged ; Feasibility Studies ; Female ; Humans ; Isometric Contraction ; Male ; Middle Aged ; Muscle Fatigue ; Phonetics ; Pressure ; Sound Spectrography ; Speech Production Measurement

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
Autorzy:: Brown AR; Department of Biostatistics, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA. .
Gajewski BJ; Department of Biostatistics, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.
Aaronson LS; School of Nursing, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Mudaranthakam DP; Department of Biostatistics, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.
Hunt SL; Department of Biostatistics, University of Kansas Medical Center, Mail Stop 1026, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.
Berry SM; Berry Consultants, 4301 Westbank Drive, Suite 140, Bldg B, Austin, TX, 78746, USA.
Quintana M; Berry Consultants, 4301 Westbank Drive, Suite 140, Bldg B, Austin, TX, 78746, USA.
Pasnoor M; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Dimachkie MM; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Jawdat O; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Herbelin L; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Barohn RJ; Department of Neurology, University of Kansas Medical Center, Kansas City, KS, 66160, USA.; Pokaż więcej
Źródło:: Trials [Trials] 2016 Aug 31; Vol. 17 (1), pp. 428. Date of Electronic Publication: 2016 Aug 31.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Bayes Theorem*
Comparative Effectiveness Research*
Research Design*
Randomized Controlled Trials as Topic/*methods
Analgesics/therapeutic use ; Data Collection/methods ; Endpoint Determination ; Humans ; Multicenter Studies as Topic ; Nervous System Diseases/drug therapy ; Sample Size ; Software ; Time Factors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis.
Autorzy:: Lee JY; Department of Neurology Yale School of Medicine New Haven Connecticut.
Stathopoulos P; Department of Neurology Yale School of Medicine New Haven Connecticut.
Gupta S; Department of Neurology Yale School of Medicine New Haven Connecticut.
Bannock JM; Department of Immunobiology Yale School of Medicine New Haven Connecticut.
Barohn RJ; Department of Neurology University of Kansas Medical Center Kansas City Kansas.
Cotzomi E; Department of Neurology Yale School of Medicine New Haven Connecticut.
Dimachkie MM; Department of Neurology University of Kansas Medical Center Kansas City Kansas.
Jacobson L; Nuffield Department of Clinical Neurosciences John Radcliffe Hospital, University of Oxford Oxford UK.
Lee CS; Department of Neurology Yale School of Medicine New Haven Connecticut.
Morbach H; Department of Immunobiology Yale School of Medicine New Haven Connecticut.
Querol L; Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau Universitat Autónoma de Barcelona Spain.
Shan JL; Department of Neurology Yale School of Medicine New Haven Connecticut.
Vander Heiden JA; Interdepartmental Program in Computational Biology and Bioinformatics Yale University New Haven Connecticut.
Waters P; Nuffield Department of Clinical Neurosciences John Radcliffe Hospital, University of Oxford Oxford UK.
Vincent A; Nuffield Department of Clinical Neurosciences John Radcliffe Hospital, University of Oxford Oxford UK.
Nowak RJ; Department of Neurology Yale School of Medicine New Haven Connecticut.
O'Connor KC; Department of Neurology Yale School of Medicine New Haven Connecticut.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2016 Apr 27; Vol. 3 (6), pp. 443-54. Date of Electronic Publication: 2016 Apr 27 (Print Publication: 2016).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.
Autorzy:: Mitsumoto H; Eleanor and Lou Gehrig MDA/ALS Research Center, Department of Neurology, Columbia University Medical Center , New York.
Factor-Litvak P
Andrews H
Goetz RR
Andrews L
Rabkin JG
McElhiney M
Nieves J
Santella RM
Murphy J
Hupf J
Singleton J
Merle D
Kilty M
Heitzman D
Bedlack RS
Miller RG
Katz JS
Forshew D
Barohn RJ
Sorenson EJ
Oskarsson B
Fernandes Filho JA
Kasarskis EJ
Lomen-Hoerth C
Mozaffar T
Rollins YD
Nations SP
Swenson AJ
Shefner JM
Andrews JA
Koczon-Jaremko BA; Pokaż więcej
Corporate Authors:: ALS COSMOS Study Group
Źródło:: Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2014 Jun; Vol. 15 (3-4), pp. 192-203. Date of Electronic Publication: 2014 Feb 24.
Typ publikacji:: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Patient Selection*
Amyotrophic Lateral Sclerosis/*epidemiology
Amyotrophic Lateral Sclerosis/*physiopathology
Oxidative Stress/*physiology
Aged ; Amyotrophic Lateral Sclerosis/genetics ; Amyotrophic Lateral Sclerosis/metabolism ; Cohort Studies ; Demography ; Disease Progression ; Female ; Humans ; Insurance Coverage/statistics & numerical data ; Male ; Middle Aged ; Skin/pathology ; Surveys and Questionnaires ; Time Factors ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Phase II trial of methotrexate in myasthenia gravis.
Autorzy:: Pasnoor M; University of Kansas Medical Center, Kansas City, Kansas, USA. />He J
Herbelin L
Dimachkie M
Barohn RJ; Pokaż więcej
Corporate Authors:: Muscle Study Group
Źródło:: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2012 Dec; Vol. 1275, pp. 23-8.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Immunosuppressive Agents/*therapeutic use
Methotrexate/*therapeutic use
Myasthenia Gravis/*drug therapy
Double-Blind Method ; Humans ; Myasthenia Gravis/physiopathology ; Placebos ; Quality of Life

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.
Autorzy:: Mittal M; Department of Neurology, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA. />Pasnoor M
Mummaneni RB
Khan S
McVey A
Saperstein D
Herbelin L
Ridings L
Wang Y
Dimachkie MM
Barohn RJ; Pokaż więcej
Źródło:: The International journal of neuroscience [Int J Neurosci] 2011 Sep; Vol. 121 (9), pp. 521-7. Date of Electronic Publication: 2011 Jun 15.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Analgesics/*therapeutic use
Dopamine Uptake Inhibitors/*therapeutic use
Neuralgia/*drug therapy
Thiophenes/*therapeutic use
gamma-Aminobutyric Acid/*analogs & derivatives
Adult ; Aged ; Aged, 80 and over ; Analgesics/adverse effects ; Dopamine Uptake Inhibitors/adverse effects ; Duloxetine Hydrochloride ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Pregabalin ; Retrospective Studies ; Thiophenes/adverse effects ; Treatment Outcome ; gamma-Aminobutyric Acid/adverse effects ; gamma-Aminobutyric Acid/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice.
Autorzy:: Gorson KC; Department of Neurology, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA. />van Schaik IN
Merkies IS
Lewis RA
Barohn RJ
Koski CL
Cornblath DR
Hughes RA
Hahn AF
Baumgarten M
Goldstein J
Katz J
Graves M
Parry G
van Doorn PA; Pokaż więcej
Źródło:: Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2010 Dec; Vol. 15 (4), pp. 326-33.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Biomedical Research/*standards
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*classification
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/*diagnosis
Practice Guidelines as Topic/*standards
Adolescent ; Adult ; Child ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/therapy ; Remission Induction ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS.
Autorzy:: Rosenfeld J; The Carolinas Neuromuscular/ALS Center, Charlotte North Carolina, Carolinas Medical Center, USA.
King RM
Jackson CE
Bedlack RS
Barohn RJ
Dick A
Phillips LH
Chapin J
Gelinas DF
Lou JS; Pokaż więcej
Źródło:: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases [Amyotroph Lateral Scler] 2008 Oct; Vol. 9 (5), pp. 266-72.
Typ publikacji:: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyotrophic Lateral Sclerosis*/drug therapy
Amyotrophic Lateral Sclerosis*/physiopathology
Creatine/*pharmacology
Creatine/*therapeutic use
Muscle Fatigue/*drug effects
Muscle Strength/*drug effects
Vital Capacity/*drug effects
Aged ; Biomarkers/metabolism ; Creatine/urine ; Disease Progression ; Double-Blind Method ; Female ; Humans ; Male ; Middle Aged ; Placebos ; Quality of Life ; Survival Rate ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
Autorzy:: Gordon PH; Department of Neurology, Columbia University, New York, USA. />Cheung YK
Levin B
Andrews H
Doorish C
Macarthur RB
Montes J
Bednarz K
Florence J
Rowin J
Boylan K
Mozaffar T
Tandan R
Mitsumoto H
Kelvin EA
Chapin J
Bedlack R
Rivner M
McCluskey LF
Pestronk A
Graves M
Sorenson EJ
Barohn RJ
Belsh JM
Lou JS
Levine T
Saperstein D
Miller RG
Scelsa SN; Pokaż więcej
Corporate Authors:: Combination Drug Selection Trial Study Group
Źródło:: Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases [Amyotroph Lateral Scler] 2008 Aug; Vol. 9 (4), pp. 212-22.
Typ publikacji:: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Amyotrophic Lateral Sclerosis/*drug therapy
Creatine/*therapeutic use
Minocycline/*therapeutic use
Neuroprotective Agents/*therapeutic use
Pyrazoles/*therapeutic use
Sulfonamides/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Celecoxib ; Creatine/administration & dosage ; Double-Blind Method ; Drug Eruptions ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Minocycline/administration & dosage ; Minocycline/adverse effects ; Neuroprotective Agents/administration & dosage ; Patient Selection ; Pyrazoles/administration & dosage ; Sulfonamides/administration & dosage ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Treatment and clinical research in myasthenia gravis: how far have we come?
Autorzy:: Barohn RJ; University of Kansas Medical Center, Department of Neurology, Mail Stop 2012, 3599 Rainbow Blvd., Kansas City, KS 66160, USA.; Pokaż więcej
Źródło:: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2008; Vol. 1132, pp. 225-32.
Typ publikacji:: Journal Article
MeSH Terms:: Myasthenia Gravis/*immunology
Myasthenia Gravis/*therapy
Humans ; Immunotherapy ; Myasthenia Gravis/classification ; Myasthenia Gravis/economics ; Randomized Controlled Trials as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Barohn, Richard J"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język